TapewireFind a company

organization · Reporting owner

THOMA BRAVO PARTNERS XII, L.P.

Disclosed activity across 3 companies

Tapewire entity
80710
SEC CIK
0001756435

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
N-able, Inc.NABL · Entity 520310% ownerJuly 19, 2021July 29, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnotes50,090,643 Reported balance Holding disclosure · report date 2021-07-19 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 50,090,643

F1: Consists of 16,333,201 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 8,202,937 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 360,326 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund XI"), 8,079,625 shares held directly by Thoma Bravo Fund XII, L.P. ("TB Fund XII"), 7,145,401 shares held directly by Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), 79,070 shares held directly by Thoma Bravo Executive Fund XII, L.P. ("TB Exec Fund XII"), 70,260 shares held directly by Thoma Bravo Executive Fund XII-A, L.P. ("TB Exec Fund XII-A"), 6,610,607 shares held directly by Thoma Bravo Special Opportunities Fund II, L.P. ("TB SOF II") and 3,209,216 shares held directly by Thoma Bravo Special Opportunities Fund II-A, L.P. ("TB SOF II-A").

F2: Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB SOF II and TB SOF II-A. Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of each of TB Fund XII, TB Fund XII-A, TB Exec Fund XII and TB Exec Fund XII-A. Thoma Bravo UGP, LLC ("TB, LLC") is the managing member of the general partner of each of TB Partners XI and TB Partners XII.

F3: (Continued from footnote 2) By virtue of the relationships described in this footnote, TB, LLC may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB SOF II and TB SOF II-A. Each of TB Partners XI, TB Partners XII and TB, LLC disclaims beneficial ownership of the shares owned by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A except to the extent of its pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Consists of 16,333,201 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 8,202,937 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 360,326 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund XI"), 8,079,625 shares held directly by Thoma Bravo Fund XII, L.P. ("TB Fund XII"), 7,145,401 shares held directly by Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), 79,070 shares held directly by Thoma Bravo Executive Fund XII, L.P. ("TB Exec Fund XII"), 70,260 shares held directly by Thoma Bravo Executive Fund XII-A, L.P. ("TB Exec Fund XII-A"), 6,610,607 shares held directly by Thoma Bravo Special Opportunities Fund II, L.P. ("TB SOF II") and 3,209,216 shares held directly by Thoma Bravo Special Opportunities Fund II-A, L.P. ("TB SOF II-A").

F2: Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB SOF II and TB SOF II-A. Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of each of TB Fund XII, TB Fund XII-A, TB Exec Fund XII and TB Exec Fund XII-A. Thoma Bravo UGP, LLC ("TB, LLC") is the managing member of the general partner of each of TB Partners XI and TB Partners XII.

F3: (Continued from footnote 2) By virtue of the relationships described in this footnote, TB, LLC may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB SOF II and TB SOF II-A. Each of TB Partners XI, TB Partners XII and TB, LLC disclaims beneficial ownership of the shares owned by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A except to the extent of its pecuniary interest therein.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Section 16 reporting ended · disclosed 2022-03-04. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeIndirectSee Explanation of Responses0 Last balance in matching sequence After 2022-03-01 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rows

Row 1 · 2022-03-01 · Conversion · Acquired 24,075,115 · Balance 40,686,250

F2: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F3: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis.

F5: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.

F6: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Row 2 · 2022-03-01 · Other · Disposed 40,686,250 · Balance 0

F4: Consists of Class A Shares that were directly held by TB Partners XII AIV, Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV (collectively, the "TB Funds").

F1: The securities reported herein were disposed of pursuant to the Agreement and Plan of Merger, dated as of November 5, 2021 (the "Merger Agreement"), by and among McAfee Corp. (the "Issuer"), Condor BidCo, Inc. ("Parent"), and Condor Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Subsidiary"), whereby the Merger Subsidiary merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time") on March 1, 2022, each share of Class A common stock (a "Class A Share") of the Issuer outstanding immediately prior to the Effective Time was automatically converted into the right to receive $26.00 in cash, subject to applicable withholding taxes.

F5: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.

F6: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Class A Unit and Class B Common StockSEC Table II · derivative / convertible securityIndirectSee Explanation of Responses0 Reported balance After 2022-03-01 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2022-03-01 · Conversion · Disposed 24,075,115 · Balance 0

F2: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F3: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis.

F5: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.

F6: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Filing footnotes · ownership attribution and instrument terms

F1: The securities reported herein were disposed of pursuant to the Agreement and Plan of Merger, dated as of November 5, 2021 (the "Merger Agreement"), by and among McAfee Corp. (the "Issuer"), Condor BidCo, Inc. ("Parent"), and Condor Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Subsidiary"), whereby the Merger Subsidiary merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time") on March 1, 2022, each share of Class A common stock (a "Class A Share") of the Issuer outstanding immediately prior to the Effective Time was automatically converted into the right to receive $26.00 in cash, subject to applicable withholding taxes.

F2: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F3: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis.

F4: Consists of Class A Shares that were directly held by TB Partners XII AIV, Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV (collectively, the "TB Funds").

F5: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.

F6: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Section 16 reporting ended · disclosed 2025-04-17. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee Footnotes0 Reported balance After 2025-04-16 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2025-04-16 · Other · Disposed 50,090,648 · Balance 0

F1: Pursuant to the Agreement and Plan of Merger dated as of February 7, 2025, by and among Starlight Parent, LLC ("Parent"), Starlight Merger Sub, Inc. ("Merger Subsidiary"), and the Issuer, Merger Subsidiary merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, and at the time of the Merger each issued and outstanding share of the Issuer's Common Stock, par value $0.001 per share, owned by the Reporting Persons was cancelled and converted into the right to receive $18.50 per share in cash without interest thereon.

F2: Consists of 16,333,202 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 8,202,937 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 360,326 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund XI"), 8,079,625 shares held directly by Thoma Bravo Fund XII, L.P. ("TB Fund XII"), 7,145,402 shares held directly by Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), 79,071 shares held directly by Thoma Bravo Executive Fund XII, L.P. ("TB Exec Fund XII"), 70,261 shares held directly by Thoma Bravo Executive Fund XII-a, L.P. ("TB Exec Fund XII-A"), 6,610,607 shares held directly by Thoma Bravo Special Opportunities Fund II, L.P. ("TB SOF II") and 3,209,217 shares held directly by Thoma Bravo Special Opportunities Fund II-A, L.P. ("TB SOF II-A").

F3: The number of securities disposed has been adjusted to reflect the 1-for-2 reverse stock split effected by the Issuer on July 30, 2021.

F4: Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB SOF II and TB SOF II-A. Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of each of TB Fund XII, TB Fund XII-A, TB Exec Fund XII and TB Exec Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate managing member of each of TB Partners XI and TB Partners XII. By virtue of the relationships described in this footnote, TB UGP may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A.

F5: (Continued from footnote 4) Each of TB Partners XI, TB Partners XII and TB UGP disclaims beneficial ownership of the shares owned by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A except to the extent of its pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger dated as of February 7, 2025, by and among Starlight Parent, LLC ("Parent"), Starlight Merger Sub, Inc. ("Merger Subsidiary"), and the Issuer, Merger Subsidiary merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, and at the time of the Merger each issued and outstanding share of the Issuer's Common Stock, par value $0.001 per share, owned by the Reporting Persons was cancelled and converted into the right to receive $18.50 per share in cash without interest thereon.

F2: Consists of 16,333,202 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 8,202,937 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 360,326 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund XI"), 8,079,625 shares held directly by Thoma Bravo Fund XII, L.P. ("TB Fund XII"), 7,145,402 shares held directly by Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), 79,071 shares held directly by Thoma Bravo Executive Fund XII, L.P. ("TB Exec Fund XII"), 70,261 shares held directly by Thoma Bravo Executive Fund XII-a, L.P. ("TB Exec Fund XII-A"), 6,610,607 shares held directly by Thoma Bravo Special Opportunities Fund II, L.P. ("TB SOF II") and 3,209,217 shares held directly by Thoma Bravo Special Opportunities Fund II-A, L.P. ("TB SOF II-A").

F3: The number of securities disposed has been adjusted to reflect the 1-for-2 reverse stock split effected by the Issuer on July 30, 2021.

F4: Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB SOF II and TB SOF II-A. Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of each of TB Fund XII, TB Fund XII-A, TB Exec Fund XII and TB Exec Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate managing member of each of TB Partners XI and TB Partners XII. By virtue of the relationships described in this footnote, TB UGP may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A.

F5: (Continued from footnote 4) Each of TB Partners XI, TB Partners XII and TB UGP disclaims beneficial ownership of the shares owned by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A except to the extent of its pecuniary interest therein.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
April 16, 2025 Filed Apr 17, 2025 17:23 UTC SolarWinds Corp SWI · Entity 80691 OtherCommon Stock 50,090,648 $18.50 $926,676,988.00
Disclosure

SEC source: 0000950170-25-055580 · ownership.xml · nonDerivative · entry 1

THOMA BRAVO UGP, LLC · CIK 0001813487 · 10% owner

THOMA BRAVO PARTNERS XI, L.P. · CIK 0001722232 · 10% owner

THOMA BRAVO FUND XI, L.P. · CIK 0001606286 · 10% owner

THOMA BRAVO FUND XI-A, L.P. · CIK 0001606287 · 10% owner

THOMA BRAVO EXECUTIVE FUND XI, L.P. · CIK 0001606288 · 10% owner

THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · 10% owner

THOMA BRAVO FUND XII, L.P. · CIK 0001666742 · 10% owner

THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · 10% owner

THOMA BRAVO EXECUTIVE FUND XII, L.P. · CIK 0001666745 · 10% owner

Thoma Bravo Executive Fund XII-a, L.P. · CIK 0001680073 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F1 · kind: Pursuant to the Agreement and Plan of Merger dated as of February 7, 2025, by and among Starlight Parent, LLC ("Parent"), Starlight Merger Sub, Inc. ("Merger Subsidiary"), and the Issuer, Merger Subsidiary merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Parent, and at the time of the Merger each issued and outstanding share of the Issuer's Common Stock, par value $0.001 per share, owned by the Reporting Persons was cancelled and converted into the right to receive $18.50 per share in cash without interest thereon.

F2 · shares: Consists of 16,333,202 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 8,202,937 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 360,326 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund XI"), 8,079,625 shares held directly by Thoma Bravo Fund XII, L.P. ("TB Fund XII"), 7,145,402 shares held directly by Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), 79,071 shares held directly by Thoma Bravo Executive Fund XII, L.P. ("TB Exec Fund XII"), 70,261 shares held directly by Thoma Bravo Executive Fund XII-a, L.P. ("TB Exec Fund XII-A"), 6,610,607 shares held directly by Thoma Bravo Special Opportunities Fund II, L.P. ("TB SOF II") and 3,209,217 shares held directly by Thoma Bravo Special Opportunities Fund II-A, L.P. ("TB SOF II-A").

F3 · shares: The number of securities disposed has been adjusted to reflect the 1-for-2 reverse stock split effected by the Issuer on July 30, 2021.

F4 · ownership.nature: Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB SOF II and TB SOF II-A. Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of each of TB Fund XII, TB Fund XII-A, TB Exec Fund XII and TB Exec Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate managing member of each of TB Partners XI and TB Partners XII. By virtue of the relationships described in this footnote, TB UGP may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A.

F5 · ownership.nature: (Continued from footnote 4) Each of TB Partners XI, TB Partners XII and TB UGP disclaims beneficial ownership of the shares owned by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A except to the extent of its pecuniary interest therein.

Read SEC document
March 01, 2022 Filed Mar 4, 2022 11:55 UTC McAfee Corp. MCFE · Entity 11636 ConversionClass A Unit and Class B Common Stock · Derivative 24,075,115 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-009345 · doc4.xml · derivative · entry 3

THOMA BRAVO UGP, LLC · CIK 0001813487 · Former 10% Owner

THOMA BRAVO PARTNERS XII AIV, L.P. · CIK 0001828302 · Former 10% Owner

THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · Former 10% Owner

THOMA BRAVO FUND XII AIV, L.P. · CIK 0001828303 · Former 10% Owner

THOMA BRAVO EXECUTIVE FUND XII AIV, L.P. · CIK 0001828305 · Former 10% Owner

THOMA BRAVO EXECUTIVE FUND XII-a AIV, L.P. · CIK 0001828304 · Former 10% Owner

THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · Former 10% Owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 0

Underlying: Class A Common Stock · 24,075,115 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F3 · derivative.exercise_price: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis.

F2 · price: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F3 · price: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis.

F2 · derivative.exercise_date: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F3 · derivative.exercise_date: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis.

F2 · derivative.expiration_date: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F3 · derivative.expiration_date: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis.

F5 · ownership.nature: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.

F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
March 01, 2022 Filed Mar 4, 2022 11:55 UTC McAfee Corp. MCFE · Entity 11636 OtherClass A Common Stock 40,686,250 $26.00 $1,057,842,500.00
Disclosure

SEC source: 0000899243-22-009345 · doc4.xml · nonDerivative · entry 2

THOMA BRAVO UGP, LLC · CIK 0001813487 · Former 10% Owner

THOMA BRAVO PARTNERS XII AIV, L.P. · CIK 0001828302 · Former 10% Owner

THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · Former 10% Owner

THOMA BRAVO FUND XII AIV, L.P. · CIK 0001828303 · Former 10% Owner

THOMA BRAVO EXECUTIVE FUND XII AIV, L.P. · CIK 0001828305 · Former 10% Owner

THOMA BRAVO EXECUTIVE FUND XII-a AIV, L.P. · CIK 0001828304 · Former 10% Owner

THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · Former 10% Owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 0

F4 · shares: Consists of Class A Shares that were directly held by TB Partners XII AIV, Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV (collectively, the "TB Funds").

F1 · price: The securities reported herein were disposed of pursuant to the Agreement and Plan of Merger, dated as of November 5, 2021 (the "Merger Agreement"), by and among McAfee Corp. (the "Issuer"), Condor BidCo, Inc. ("Parent"), and Condor Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Subsidiary"), whereby the Merger Subsidiary merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time") on March 1, 2022, each share of Class A common stock (a "Class A Share") of the Issuer outstanding immediately prior to the Effective Time was automatically converted into the right to receive $26.00 in cash, subject to applicable withholding taxes.

F5 · ownership.nature: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.

F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
March 01, 2022 Filed Mar 4, 2022 11:55 UTC McAfee Corp. MCFE · Entity 11636 ConversionClass A Common Stock 24,075,115 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-009345 · doc4.xml · nonDerivative · entry 1

THOMA BRAVO UGP, LLC · CIK 0001813487 · Former 10% Owner

THOMA BRAVO PARTNERS XII AIV, L.P. · CIK 0001828302 · Former 10% Owner

THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · Former 10% Owner

THOMA BRAVO FUND XII AIV, L.P. · CIK 0001828303 · Former 10% Owner

THOMA BRAVO EXECUTIVE FUND XII AIV, L.P. · CIK 0001828305 · Former 10% Owner

THOMA BRAVO EXECUTIVE FUND XII-a AIV, L.P. · CIK 0001828304 · Former 10% Owner

THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · Former 10% Owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 40,686,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F3 · shares: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis.

F2 · price: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV") had the right to exchange all or a portion of its Class A units (the "Common Units") of Foundation Technology Worldwide LLC (together with an equal number of shares of Class B common stock (the "Class B Shares") of the Issuer) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F3 · price: Immediately prior to the Effective Time on March 1, 2022, pursuant to the terms of the Merger Agreement, TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV exchanged all of their Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis.

F5 · ownership.nature: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to have exercised voting and dispositive power with respect to the securities reported herein formerly held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.

F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

Read SEC document
December 07, 2020 Filed Dec 9, 2020 20:13 UTC SolarWinds Corp SWI · Entity 80691 SaleCommon Stock 5,839,157 $21.97 $128,286,279.29
Disclosure

SEC source: 0000899243-20-033220 · doc4.xml · nonDerivative · entry 1

THOMA BRAVO UGP, LLC · CIK 0001813487 · 10% owner

THOMA BRAVO PARTNERS XI, L.P. · CIK 0001722232 · 10% owner

THOMA BRAVO FUND XI, L.P. · CIK 0001606286 · 10% owner

THOMA BRAVO FUND XI-A, L.P. · CIK 0001606287 · 10% owner

THOMA BRAVO EXECUTIVE FUND XI, L.P. · CIK 0001606288 · 10% owner

THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · 10% owner

THOMA BRAVO FUND XII, L.P. · CIK 0001666742 · 10% owner

THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · 10% owner

THOMA BRAVO EXECUTIVE FUND XII, L.P. · CIK 0001666745 · 10% owner

Thoma Bravo Executive Fund XII-a, L.P. · CIK 0001680073 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 100,181,291

F1 · shares: Consists of 1,903,990 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 956,231 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 42,004 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund XI"), 941,857 shares held directly by Thoma Bravo Fund XII, L.P. ("TB Fund XII"), 832,953 shares held directly by Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), 9,217 shares held directly by Thoma Bravo Executive Fund XII, L.P. ("TB Exec Fund XII"), 8,190 shares held directly by Thoma Bravo Executive Fund XII-A, L.P. ("TB Exec Fund XII-A"), 770,611 shares held directly by Thoma Bravo Special Opportunities Fund II, L.P. ("TB SOF II") and 374,104 shares held directly by Thoma Bravo Special Opportunities Fund II-A, L.P. ("TB SOF II-A").

F2 · price: On December 7, 2020, each of the foregoing reporting persons entered in a Stock Purchase Agreement to sell shares of common stock at a price of $21.97 per share, subject to potential adjustment under certain circumstances.

F3 · balance_after: Consists of 32,666,403 shares held directly by TB Fund XI, 16,405,874 shares held directly by TB Fund XI-A, 720,652 shares held directly by TB Exec Fund XI, 16,159,250 shares held directly by TB Fund XII, 14,290,803 shares held directly by TB Fund XII-A, 158,141 shares held directly by TB Exec Fund XII, 140,521 shares held directly by TB Exec Fund XII-A, 13,221,214 shares held directly by TB SOF II and 6,418,433 shares held directly by TB SOF II-A.

F4 · ownership.nature: Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB SOF II and TB SOF II-A. Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of each of TB Fund XII, TB Fund XII-A, TB Exec Fund XII and TB Exec Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate managing member of each of TB Partners XI and TB Partners XII. By virtue of the relationships described in this footnote, TB UGP may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A.

F5 · ownership.nature: (Continued from footnote 4) Each of TB Partners XI, TB Partners XII and TB UGP disclaims beneficial ownership of the shares owned by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A except to the extent of its pecuniary interest therein.

Read SEC document
October 26, 2020 Filed Oct 28, 2020 16:30 UTC McAfee Corp. MCFE · Entity 11636 OtherClass A Unit and Class B Common Stock · Derivative 470,263 $18.90 $8,887,970.70
Disclosure

SEC source: 0000899243-20-029508 · doc4.xml · derivative · entry 2

THOMA BRAVO UGP, LLC · CIK 0001813487 · 10% owner

THOMA BRAVO PARTNERS XII AIV, L.P. · CIK 0001828302 · 10% owner

THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · 10% owner

THOMA BRAVO FUND XII AIV, L.P. · CIK 0001828303 · 10% owner

THOMA BRAVO EXECUTIVE FUND XII AIV, L.P. · CIK 0001828305 · 10% owner

THOMA BRAVO EXECUTIVE FUND XII-a AIV, L.P. · CIK 0001828304 · 10% owner

THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 24,264,482

Underlying: Class A Common Stock · 470,263 shares

Expires not disclosed

F3 · derivative.exercise_price: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV may exchange all or a portion of its Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F4 · kind: On October 26, 2020, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV sold an aggregate of 470,263 Common Units (together with an equal number of Class B Shares) to the Issuer at a price of $18.90 per Common Unit/Class B Share.

F3 · derivative.exercise_date: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV may exchange all or a portion of its Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F3 · derivative.expiration_date: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV may exchange all or a portion of its Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F2 · ownership.nature: Consists of 2,364,188 Class A units ("Common Units") of Foundation Technology Worldwide LLC directly held by TB Partners XII AIV, 21,502,869 Common Units directly held by TB Fund XII AIV, 210,435 Common Units directly held by TB Exec Fund XII AIV and 186,990 Common Units directly held by TB Exec Fund XII-a AIV, in each case, together with an equal number of shares of Class B Common Stock ("Class B Shares") of the Issuer.

F3 · ownership.nature: Pursuant to the Second Amended and Restated Limited Liability Company Agreement of Foundation Technology Worldwide LLC, as amended, each of TB Partners XII AIV, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV may exchange all or a portion of its Common Units (together with an equal number of Class B Shares) for Class A Shares on a one-for-one basis, subject to customary adjustments, or, at the option of the Issuer, cash (based on the then-market value of the Class A Shares).

F4 · ownership.nature: On October 26, 2020, TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV sold an aggregate of 470,263 Common Units (together with an equal number of Class B Shares) to the Issuer at a price of $18.90 per Common Unit/Class B Share.

F5 · ownership.nature: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to exercise voting and dispositive power with respect to the securities reported herein held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.

F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

F7 · ownership.nature: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act.

Read SEC document
October 26, 2020 Filed Oct 28, 2020 16:30 UTC McAfee Corp. MCFE · Entity 11636 SaleClass A Common Stock 408,340 $18.90 $7,717,626.00
Disclosure

SEC source: 0000899243-20-029508 · doc4.xml · nonDerivative · entry 1

THOMA BRAVO UGP, LLC · CIK 0001813487 · 10% owner

THOMA BRAVO PARTNERS XII AIV, L.P. · CIK 0001828302 · 10% owner

THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · 10% owner

THOMA BRAVO FUND XII AIV, L.P. · CIK 0001828303 · 10% owner

THOMA BRAVO EXECUTIVE FUND XII AIV, L.P. · CIK 0001828305 · 10% owner

THOMA BRAVO EXECUTIVE FUND XII-a AIV, L.P. · CIK 0001828304 · 10% owner

THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Explanation of Responses

Disclosed balance after: 18,852,120

F1 · ownership.nature: Consists of 71,344 shares of Class A common stock ("Class A Shares") of McAfee Corp. (the "Issuer") directly held by Thoma Bravo Partners XII AIV, L.P. ("TB Partners XII AIV"), 17,603,384 Class A Shares directly held Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), 1,156,028 Class A Shares directly held by Thoma Bravo Fund XII AIV, L.P. ("TB Fund XII AIV"), 11,312 Class A Shares directly held by Thoma Bravo Executive Fund XII AIV, L.P. ("TB Exec Fund XII AIV") and 10,052 Class A Shares directly held by Thoma Bravo Executive Fund XII-a AIV, L.P. ("TB Exec Fund XII-a AIV" and, collectively with each of the foregoing, the "TB Funds").

F5 · ownership.nature: TB Partners XII AIV is the general partner of each of TB Fund XII AIV, TB Exec Fund XII AIV and TB Exec Fund XII-a AIV, and Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of TB Fund XII-A. Thoma Bravo UGP, LLC ("TB UGP") is the ultimate general partner of TB Partners XII AIV and TB Partners XII. Because of the relationships described in this footnote, TB UGP may be deemed to exercise voting and dispositive power with respect to the securities reported herein held by the TB Funds. Each TB Fund, TB Partners XII and TB UGP disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, if any.

F6 · ownership.nature: Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the reporting persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests.

F7 · ownership.nature: The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act.

Read SEC document
May 28, 2019 Filed May 30, 2019 17:09 UTC SolarWinds Corp SWI · Entity 80691 SaleCommon Stock 6,108,870 $17.42 $106,385,971.05
Disclosure

SEC source: 0000899243-19-015192 · doc4.xml · nonDerivative · entry 1

Thoma Bravo, LLC · CIK 0001450701 · 10% owner

THOMA BRAVO PARTNERS XI, L.P. · CIK 0001722232 · 10% owner

THOMA BRAVO FUND XI, L.P. · CIK 0001606286 · 10% owner

THOMA BRAVO FUND XI-A, L.P. · CIK 0001606287 · 10% owner

THOMA BRAVO EXECUTIVE FUND XI, L.P. · CIK 0001606288 · 10% owner

THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · 10% owner

THOMA BRAVO FUND XII, L.P. · CIK 0001666742 · 10% owner

THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · 10% owner

THOMA BRAVO EXECUTIVE FUND XII, L.P. · CIK 0001666745 · 10% owner

Thoma Bravo Executive Fund XII-a, L.P. · CIK 0001680073 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 106,020,448

F1 · shares: Consists of 1,991,937 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 1,000,400 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 43,944 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund XI"), 985,361 shares held directly by Thoma Bravo Fund XII, L.P. ("TB Fund XII"), 871,427 shares held directly by Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), 9,643 shares held directly by Thoma Bravo Executive Fund XII, L.P. ("TB Exec Fund XII"), 8,569 shares held directly by Thoma Bravo Executive Fund XII-A, L.P. ("TB Exec Fund XII-A"), 806,205 shares held directly by Thoma Bravo Special Opportunities Fund II, L.P. ("TB SOF II") and 391,384 shares held directly by Thoma Bravo Special Opportunities Fund II-A, L.P. ("TB SOF II-A").

F2 · price: The proceeds per share, before expenses, to the selling stockholders of the secondary public offering is $17.415, equal to $18.00 per share, the public offering price per share of common stock, less an amount equal to the underwriting discount of $0.585 per share.

F3 · balance_after: Consists of 34,570,393 shares held directly by TB Fund XI, 17,362,105 shares held directly by TB Fund XI-A, 762,656 shares held directly by TB Exec Fund XI, 17,101,107 shares held directly by TB Fund XII, 15,123,756 shares held directly by TB Fund XII-A, 167,358 shares held directly by TB Exec Fund XII, 148,711 shares held directly by TB Exec Fund XII-A, 13,991,825 shares held directly by TB SOF II and 6,792,537 shares held directly by TB SOF II-A.

F4 · ownership.nature: Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB SOF II and TB SOF II-A. Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of each of TB Fund XII, TB Fund XII-A, TB Exec Fund XII and TB Exec Fund XII-A. Thoma Bravo, LLC ("TB, LLC") is the general partner of each of TB Partners XI and TB Partners XII. By virtue of the relationships described in this footnote, TB, LLC may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A. Each of TB Partners XI, TB Partners XII and TB, LLC disclaims beneficial ownership of the shares owned by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A except to the extent of its pecuniary interest therein.

Read SEC document
October 23, 2018 Filed Oct 24, 2018 16:16 UTC SolarWinds Corp SWI · Entity 80691 ConversionClass A Common Stock · Derivative 1,076,505 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-18-027351 · doc4.xml · derivative · entry 2

Thoma Bravo, LLC · CIK 0001450701 · 10% owner

THOMA BRAVO PARTNERS XI, L.P. · CIK 0001722232 · 10% owner

THOMA BRAVO FUND XI, L.P. · CIK 0001606286 · 10% owner

THOMA BRAVO FUND XI-A, L.P. · CIK 0001606287 · 10% owner

THOMA BRAVO EXECUTIVE FUND XI, L.P. · CIK 0001606288 · 10% owner

THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · 10% owner

THOMA BRAVO FUND XII, L.P. · CIK 0001666742 · 10% owner

THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · 10% owner

THOMA BRAVO EXECUTIVE FUND XII, L.P. · CIK 0001666745 · 10% owner

Thoma Bravo Executive Fund XII-a, L.P. · CIK 0001680073 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 71,943,846 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F2 · kind: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F6 · shares: Consists of 351,143 shares held directly by TB Fund XI, 176,353 shares held directly by TB Fund XI-A, 7,747 shares held directly by TB Exec Fund XI, 173,640 shares held directly by TB Fund XII, 153,563 shares held directly by TB Fund XII-A, 1,699 shares held directly by TB Exec Fund XII, 1,510 shares held directly by TB Exec Fund XII-A, 141,942 shares held directly by TB SOF II and 68,908 shares held directly by TB SOF II-A.

F2 · price: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F2 · derivative.exercise_date: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F2 · derivative.expiration_date: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F1 · derivative.underlying: Immediately prior to the completion of the Issuer's initial public offering and following the conversion of the Issuer's Class A Common Stock into Class B Common Stock, each share of Class B Common Stock was reclassified into one share of Common Stock.

F2 · derivative.underlying_shares: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F3 · derivative.underlying_shares: Consists of 23,454,308 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 11,779,333 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 517,424 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund XI"), 11,604,548 shares held directly by Thoma Bravo Fund XII, L.P. ("TB Fund XII"), 10,262,749 shares held directly by Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), 113,566 shares held directly by Thoma Bravo Executive Fund XII, L.P. ("TB Exec Fund XII"), 100,913 shares held directly by Thoma Bravo Executive Fund XII-A, L.P. ("TB Exec Fund XII-A"), 9,499,388 shares held directly by Thoma Bravo Special Opportunities Fund II, L.P. ("TB SOF II") and 4,611,617 shares held directly by Thoma Bravo Special Opportunities Fund II-A, L.P. ("TB SOF II-A").

F5 · ownership.nature: Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB SOF II and TB SOF II-A. Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of each of TB Fund XII, TB Fund XII-A, TB Exec Fund XII and TB Exec Fund XII-A. Thoma Bravo, LLC ("TB, LLC") is the general partner of each of TB Partners XI and TB Partners XII. By virtue of the relationships described in this footnote, TB, LLC may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB SOF II and TB SOF II-A. Each of TB Partners XI, TB Partners XII and TB, LLC disclaims beneficial ownership of the shares owned by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A except to the extent of its pecuniary interest therein.

Read SEC document
October 23, 2018 Filed Oct 24, 2018 16:16 UTC SolarWinds Corp SWI · Entity 80691 ConversionCommon Stock 71,943,846 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-18-027351 · doc4.xml · nonDerivative · entry 1

Thoma Bravo, LLC · CIK 0001450701 · 10% owner

THOMA BRAVO PARTNERS XI, L.P. · CIK 0001722232 · 10% owner

THOMA BRAVO FUND XI, L.P. · CIK 0001606286 · 10% owner

THOMA BRAVO FUND XI-A, L.P. · CIK 0001606287 · 10% owner

THOMA BRAVO EXECUTIVE FUND XI, L.P. · CIK 0001606288 · 10% owner

THOMA BRAVO PARTNERS XII, L.P. · CIK 0001756435 · 10% owner

THOMA BRAVO FUND XII, L.P. · CIK 0001666742 · 10% owner

THOMA BRAVO FUND XII-A, L.P. · CIK 0001666747 · 10% owner

THOMA BRAVO EXECUTIVE FUND XII, L.P. · CIK 0001666745 · 10% owner

Thoma Bravo Executive Fund XII-a, L.P. · CIK 0001680073 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 112,129,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Immediately prior to the completion of the Issuer's initial public offering and following the conversion of the Issuer's Class A Common Stock into Class B Common Stock, each share of Class B Common Stock was reclassified into one share of Common Stock.

F2 · kind: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F3 · shares: Consists of 23,454,308 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 11,779,333 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 517,424 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund XI"), 11,604,548 shares held directly by Thoma Bravo Fund XII, L.P. ("TB Fund XII"), 10,262,749 shares held directly by Thoma Bravo Fund XII-A, L.P. ("TB Fund XII-A"), 113,566 shares held directly by Thoma Bravo Executive Fund XII, L.P. ("TB Exec Fund XII"), 100,913 shares held directly by Thoma Bravo Executive Fund XII-A, L.P. ("TB Exec Fund XII-A"), 9,499,388 shares held directly by Thoma Bravo Special Opportunities Fund II, L.P. ("TB SOF II") and 4,611,617 shares held directly by Thoma Bravo Special Opportunities Fund II-A, L.P. ("TB SOF II-A").

F2 · price: Immediately prior to the completion of the Issuer's initial public offering, each outstanding share of Class A Common Stock automatically converted into a number of shares of Class B Common Stock equal to the result of the liquidation value of such share of Class A Common Stock divided by $19.00. The liquidation value for each share of Class A Common Stock was equal to $1,000 plus accrued and unpaid dividends on such share of Class A Common Stock through October 18, 2018. In addition, the shares of the Issuer's Class A Common Stock were convertible, at the option of the holder, into shares of Class B Common Stock for a specified period of time ending on November 7, 2018.

F4 · balance_after: Consists of 36,562,330 shares held directly by TB Fund XI, 18,362,505 shares held directly by TB Fund XI-A, 806,600 shares held directly by TB Exec Fund XI, 18,086,468 shares held directly by TB Fund XII, 15,995,183 shares held directly by TB Fund XII-A, 177,001 shares held directly by TB Exec Fund XII, 157,280 shares held directly by TB Exec Fund XII-A, 14,798,030 shares held directly by TB SOF II and 7,183,921 shares held directly by TB SOF II-A.

F5 · ownership.nature: Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB SOF II and TB SOF II-A. Thoma Bravo Partners XII, L.P. ("TB Partners XII") is the general partner of each of TB Fund XII, TB Fund XII-A, TB Exec Fund XII and TB Exec Fund XII-A. Thoma Bravo, LLC ("TB, LLC") is the general partner of each of TB Partners XI and TB Partners XII. By virtue of the relationships described in this footnote, TB, LLC may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB SOF II and TB SOF II-A. Each of TB Partners XI, TB Partners XII and TB, LLC disclaims beneficial ownership of the shares owned by TB Fund XI, TB Fund XI-A, TB Exec Fund XI, TB Fund XII, TB Fund XII-A, TB Exec Fund XII, TB Exec Fund XII-A, TB SOF II and TB SOF II-A except to the extent of its pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.